A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group. - Shand,N.; Weber,F.; Mariani,L. (Hum Gene Ther, 1999)